Salesforce Ventures contributed to an $11.5m round that will fund the addition of more features to Acto's mobile drug information platform.
Acto, the Canada-based developer of a medical product engagement platform, completed an $11.5m series A round yesterday backed by enterprise software provider Salesforce through corporate venturing subsidiary Salesforce Ventures.
Growth equity firm Resolve Growth Partners led the round, which also featured venture capital firm Panache Ventures.
Founded in 2014, Acto has built a mobile-based platform that helps pharmaceutical field representatives interact with doctors and patients. It also allows doctors, nurses and patients to access information on drugs and medical devices.
…
